Warning letter
Sagemax Bioceramics, Inc.: warning letter of Dec 9, 2014
FDA warning letter 439941 · Seattle District Office
Key facts
| Reference number | 439941 |
|---|---|
| Company | Sagemax Bioceramics, Inc. |
| Subject | CGMP/QSR/Medical Devices/Adulterated/Misbranded |
| Issue date | Dec 9, 2014 |
| Posted date | Dec 23, 2014 |
| Issuing office | Seattle District Office |
| Product type | Devices |
| CFR sections cited | 820, 807.97 |
| Inspection city | Federal Way |
| Inspection ZIP | 98003 |
| Inspection start date | Aug 11, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: